# Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast Carcinoma

> **NCT05339113** · NA · UNKNOWN · sponsor: **The National Center of Oncology, Azerbaijan** · enrollment: 100 (estimated)

## Conditions studied

- Breast Neoplasms
- Positron Emission Tomography
- Fibroblast Activation Protein Inhibitor
- Fluorodeoxyglucose F18

## Interventions

- **DIAGNOSTIC_TEST:** 68Ga-FAPI-46 PET/CT

## Key facts

- **NCT ID:** NCT05339113
- **Lead sponsor:** The National Center of Oncology, Azerbaijan
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-04
- **Primary completion:** 2022-09
- **Final completion:** 2022-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05339113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05339113, "Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast Carcinoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05339113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*